Astrana Health Net Income Over Time
| ASTH Stock | 22.03 0.75 3.52% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Astrana Health Performance and Astrana Health Correlation. Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Earnings Share 0.2 | Revenue Per Share | Quarterly Revenue Growth 0.997 | Return On Assets |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Astrana Health and related stocks such as Ensign Group, Align Technology, and Universal Health Services Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENSG | 3.6 M | 47.7 M | 40.6 M | 24 M | 36 M | 55.4 M | 50 M | 40.5 M | 92.4 M | 110.5 M | 170.5 M | 194.7 M | 224.7 M | 209.4 M | 298 M | 342.7 M | 359.8 M |
| ALGN | (15.4 M) | 66.7 M | 58.7 M | 64.3 M | 145.8 M | 144 M | 189.7 M | 231.4 M | 400.2 M | 442.8 M | 1.8 B | 772 M | 361.6 M | 445.1 M | 421.4 M | 484.6 M | 508.8 M |
| UHS | 21.7 M | 398.2 M | 443.4 M | 510.7 M | 545.3 M | 680.5 M | 702.4 M | 752.3 M | 779.7 M | 814.9 M | 944 M | 991.6 M | 675.6 M | 717.8 M | 1.1 B | 1.3 B | 1.4 B |
| ATR | 19.5 M | 183.7 M | 162.6 M | 172 M | 191.7 M | 199.3 M | 205.6 M | 220 M | 194.7 M | 242.2 M | 214 M | 244.1 M | 239.3 M | 284.5 M | 374.5 M | 430.7 M | 452.3 M |
| BIO | 4.3 M | 178.2 M | 169.2 M | 77.8 M | 88.8 M | 113.1 M | 28.1 M | 114.7 M | 361 M | 1.8 B | 3.8 B | 4.3 B | (3.6 B) | (637.3 M) | (1.8 B) | (2.1 B) | (2 B) |
| CHE | 21.9 M | 86 M | 89.3 M | 77.2 M | 99.3 M | 110.3 M | 108.7 M | 98.2 M | 205.5 M | 219.9 M | 319.5 M | 268.6 M | 249.6 M | 272.5 M | 302 M | 347.3 M | 364.7 M |
| MOH | 9.5 M | 20.8 M | 9.8 M | 52.9 M | 62.2 M | 143 M | 8 M | (512 M) | 707 M | 737 M | 673 M | 659 M | 792 M | 1.1 B | 1.2 B | 1.4 B | 1.4 B |
| RVMD | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (31.1 M) | (41.8 M) | (47.7 M) | (108.2 M) | (187.1 M) | (248.7 M) | (436.4 M) | (600.1 M) | (540.1 M) | (513.1 M) |
| BMRN | (12.3 M) | (53.8 M) | (114.3 M) | (176.4 M) | (134 M) | (171.8 M) | (630.2 M) | (117 M) | (77.2 M) | (23.8 M) | 854 M | (64.1 M) | 141.6 M | 167.6 M | 426.9 M | 26.8 M | 28.1 M |
| HSIC | (10.9 M) | 367.7 M | 388.1 M | 444.1 M | 466.1 M | 479.1 M | 506.8 M | 406.3 M | 535.9 M | 508 M | 402.2 M | 623.9 M | 538 M | 416 M | 390 M | 448.5 M | 301.7 M |
Astrana Health and related stocks such as Ensign Group, Align Technology, and Universal Health Services Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Astrana Health financial statement analysis. It represents the amount of money remaining after all of Astrana Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Astrana Health | ASTH |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 1668 S Garfield |
| Exchange | NASDAQ Exchange |
null 22.03
Check out Astrana Health Performance and Astrana Health Correlation. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Astrana Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.